期刊文献+

Evaluation of intraoperative radiotherapy for gastric carcinoma with D2 and D3 surgical resection 被引量:9

Evaluation of intraoperative radiotherapy for gastric carcinoma with D2 and D3 surgical resection
下载PDF
导出
摘要 AIM: TO study the proper sites and doses of intraoperative radiotherapy (IORT) for gastric carcinoma and the effects of this treatment. METHODS: A total of 106 patients with stage Ⅰ -Ⅳ gastric carcinoma who received D2 or D3 radical operation combined with IORT were analyzed. Sixty-seven patients with gastric cancer of the antrum and body underwent distal gastrectomy. The sites of irradiation were at the celiac artery and hepatoduodenal ligment area. Another 39 patients with carcinoma of the cardia and upper part of the gastric body and whole stomach underwent proximal gastrectomy or total gastrectomy. The sites of irradiation for this group were the upper margin of the pancreas and the regional para-aorta. The therapeutic effects (including survival and complications) of these 106 cases received operation combined with IORT (IORT group) were compared with 441 cases treated during the same time period by a radical operation alone (operation group). RESULTS: The radiation dose below 30 Gy was safe. The therapeutic method of the operation combined with IORT did not prolong the survival of patients with stage Ⅰ and Ⅳ gastric cancer, but the 5-year survival rates of patients with stage Ⅱ and Ⅲ gastric cancers were significantly improved. The 5-year survival rates of the stages Ⅲ cancer patients receiving D2 resection combined with IORT were markedly improved, while for those receiving D3 radical resection, only the postoperative 3- or 4-year survival rates were improved (P 〈 0.005-0.001). The 5-year survival rate for those patients was raised only by 4.7% (P 〉 0.05). CONCLUSION: The 5-year survival rates of patients with stages Ⅱ and Ⅲ gastric carcinoma who received D2 lymphadenectomy combined with IORT were improved, and there was no influence on the postoperative complications and mortality. AIM: To study the proper sites and doses of intraopera- tive radiotherapy (IORT) for gastric carcinoma and the effects of this treatment. METHODS: A total of 106 patients with stageⅠ-Ⅳ gas- tric carcinoma who received D2 or D3 radical operation combined with IORT were analyzed. Sixty-seven patients with gastric cancer of the antrum and body underwent distal gastrectomy. The sites of irradiation were at the celiac artery and hepatoduodenal ligment area. Another 39 patients with carcinoma of the cardia and upper part of the gastric body and whole stomach underwent proximal gastrectomy or total gastrectomy. The sites of irradiation for this group were the upper margin of the pancreas and the regional para-aorta. The therapeutic effects (including survival and complications) of these 106 cases received operation combined with IORT (IORT group) were compared with 441 cases treated during the same time period by a radical operation alone (operation group). RESULTS: The radiation dose below 30 Gy was safe. The therapeutic method of the operation combined with IORT did not prolong the survival of patients with stage I and Ⅳ gastric cancer, but the 5-year survival rates of pa- tients with stage Ⅱ and Ⅲ gastric cancers were signifi- cantly improved. The 5-year survival rates of the stages Ⅲ cancer patients receiving D2 resection combined with IORT were markedly improved, while for those receiving D3 radical resection, only the postoperative 3- or 4-year survival rates were improved (P < 0.005-0.001). The 5-year survival rate for those patients was raised only by 4.7% (P > 0.05). CONCLUSION: The 5-year survival rates of patients with stages Ⅱ and Ⅲ gastric carcinoma who received D2 lymphadenectomy combined with IORT were improved, and there was no influence on the postoperative compli- cations and mortality.
机构地区 Departmentof Surgery
出处 《World Journal of Gastroenterology》 SCIE CAS CSCD 2006年第43期7033-7037,共5页 世界胃肠病学杂志(英文版)
关键词 Gastric carcinoma Intraoperative radiotherapy Surgical resection 手术治疗 放射治疗 胃癌 病理机制
  • 相关文献

参考文献19

  • 1[1]Cuschieri A,Weeden S,Fielding J,Bancewicz J,Craven J,Joypaul V,Sydes M,Fayers P.Patient survival after D1 and D2 resections for gastric cancer:long-term results of the MRC randomized surgical trial.Surgical Co-operative Group.Br J Cancer 1999; 79:1522-1530
  • 2[2]Coquard R,Ayzac L,Gilly FN,Rocher FP,Romestaing P,Sentenac I,Francois Y,Vignal J,Braillon G,Gerard JP.Intraoperative radiation therapy combined with limited lymph node resection in gastric cancer:an alternative to extended dissection? Int J Radiat Oncol Biol Phys 1997; 39:1093-108
  • 3[3]Minsky BD.The role of radiation therapy in gastric cancer.Semin Oncol 1996; 23:390-396
  • 4[4]Abe M,Yabumoto E,Takahashi M,Tobe T,Mori K.Intraoperative radiotherapy of gastric cancer.Cancer 1974; 34:2034-2041
  • 5[5]Abe M,Nishimura Y,Shibamoto Y.Intraoperative radiation therapy for gastric cancer.World J Surg 1995; 19:544-547
  • 6[6]World Health Organization.WHO Handbook for reporting results of Cancer treatment[WHO Offset Publication No 48].Geneva,Switzerland:World Health Organization,1979
  • 7[7]Gunderson LL,Sosin H.Adenocarcinoma of the stomach:areas of failure in a re-operation series (second or symptomatic look) clinicopathologic correlation and implications for adjuvant therapy.Int J Radiat Oncol Biol Phys 1982; 8:1-11
  • 8[8]Zhang ZX,Gu XZ,Yin WB,Huang GJ,Zhang DW,Zhang RG.Randomized clinical trial on the combination of preoperative irradiation and surgery in the treatment of adenocarcinoma of gastric cardia (AGC)--report on 370 patients.Int J Radiat Oncol Biol Phys 1998; 42:929-934
  • 9[9]Beck C.On external roentgen treatment of internal structures.N Y Med 1909; 89:621-622
  • 10[10]Hayes N,Ng EK,Raimes SA,Crofts TJ,Woods SD,Griffin SM,Chung SC.Total gastrectomy with extended lymphadenectomy for "curable" stomach cancer:experience in a non-Japanese Asian center.J Am Coll Surg 1999; 188:27-32

同被引文献36

引证文献9

二级引证文献29

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部